Joy Ardjuna van der Pol (Joy A van der Pol)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 10

Top Topics

Rheumatoid Arthritis

Disease Activity

Glycemic Control

Top Venues

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Joy Ardjuna van der Pol, Cornelia F Allaart, Willem F Lems, Sjoerd M van der Kooij, Thomas Wj Huizinga, Sytske Anne Bergstra
Prednisone use, disease activity and the occurrence of hyperglycaemia and diabetes in patients with early rheumatoid arthritis: a 10-year subanalysis of the BeSt study. RMD open 10 (2) (2024)
Joy Ardjuna van der Pol, Cornelia F Allaart, Thomas Wj Huizinga, Sytske Anne Bergstra
Are poor prognostic factors a realistic basis for treatment decisions in patients with rheumatoid arthritis? Lessons from the IMPROVED study. RMD open 10 (2) (2024)
Meriem Manaï, Henriët van Middendorp, Joy Ardjuna van der Pol, Cornelia F Allaart, Elise Dusseldorp, Dieuwke S Veldhuijzen, Tom W J Huizinga, Andrea W M Evers
Can Pharmacological Conditioning as an Add-On Treatment Optimize Standard Pharmacological Treatment in Patients with Recent-Onset Rheumatoid Arthritis? A Proof-of-Principle Randomized Clinical Trial. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Meriem Manaï, Henriët van Middendorp, Joy Ardjuna van der Pol, Cornelia F Allaart, Elise Dusseldorp, Dieuwke S Veldhuijzen, Tom W J Huizinga, Andrea W M Evers
Can Pharmacological Conditioning as an Add-On Treatment Optimize Standard Pharmacological Treatment in Patients with Recent-Onset Rheumatoid Arthritis? A Proof-of-Principle Randomized Clinical Trial. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Joy Ardjuna van der Pol, Cornelia F Allaart, Willem F Lems, Sjoerd M van der Kooij, Thomas Wj Huizinga, Sytske Anne Bergstra
Prednisone use, disease activity and the occurrence of hyperglycaemia and diabetes in patients with early rheumatoid arthritis: a 10-year subanalysis of the BeSt study. RMD open 10 (2) (2024)
Joy Ardjuna van der Pol, Cornelia F Allaart, Willem F Lems, Sjoerd M van der Kooij, Thomas Wj Huizinga, Sytske Anne Bergstra
Prednisone use, disease activity and the occurrence of hyperglycaemia and diabetes in patients with early rheumatoid arthritis: a 10-year subanalysis of the BeSt study. RMD open 10 (2) (2024)
Joy Ardjuna van der Pol, Cornelia F Allaart, Thomas Wj Huizinga, Sytske Anne Bergstra
Are poor prognostic factors a realistic basis for treatment decisions in patients with rheumatoid arthritis? Lessons from the IMPROVED study. RMD open 10 (2) (2024)
Joy Ardjuna van der Pol, Cornelia F Allaart, Willem F Lems, Sjoerd M van der Kooij, Thomas Wj Huizinga, Sytske Anne Bergstra
Prednisone use, disease activity and the occurrence of hyperglycaemia and diabetes in patients with early rheumatoid arthritis: a 10-year subanalysis of the BeSt study. RMD open 10 (2) (2024)
Meriem Manaï, Henriët van Middendorp, Joy Ardjuna van der Pol, Cornelia F Allaart, Elise Dusseldorp, Dieuwke S Veldhuijzen, Tom W J Huizinga, Andrea W M Evers
Can Pharmacological Conditioning as an Add-On Treatment Optimize Standard Pharmacological Treatment in Patients with Recent-Onset Rheumatoid Arthritis? A Proof-of-Principle Randomized Clinical Trial. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Joy Ardjuna van der Pol, Gülşah Akdemir, Marianne van den Broek, Linda Dirven, Pit J S M Kerstens, Willem F Lems, Iris M Markusse, Thomas Wj Huizinga, Cornelia F Allaart
Repair of joint damage in patients with rheumatoid arthritis does not relate to previous suppression of inflammation: a subanalysis after 8 years treat-to-target in the BeSt-trial. RMD open 9 (2) (2023)